Search details
1.
Antibody agonists trigger immune receptor signaling through local exclusion of receptor-type protein tyrosine phosphatases.
Immunity
; 57(2): 256-270.e10, 2024 Feb 13.
Article
in English
| MEDLINE | ID: mdl-38354703
2.
A repair pathway lost in multiple sclerosis provides a new drug opportunity.
Nat Immunol
; 25(3): 385-386, 2024 Mar.
Article
in English
| MEDLINE | ID: mdl-38409258
3.
Elevated genetic risk for multiple sclerosis emerged in steppe pastoralist populations.
Nature
; 625(7994): 321-328, 2024 Jan.
Article
in English
| MEDLINE | ID: mdl-38200296
4.
TNF receptor 1 genetic risk mirrors outcome of anti-TNF therapy in multiple sclerosis.
Nature
; 488(7412): 508-511, 2012 Aug 23.
Article
in English
| MEDLINE | ID: mdl-22801493
5.
Bridging the gap from genetic association to functional understanding: the next generation of mouse models of multiple sclerosis.
Immunol Rev
; 248(1): 10-22, 2012 Jul.
Article
in English
| MEDLINE | ID: mdl-22725951
6.
CD8⺠MAIT cells infiltrate into the CNS and alterations in their blood frequencies correlate with IL-18 serum levels in multiple sclerosis.
Eur J Immunol
; 44(10): 3119-28, 2014 Oct.
Article
in English
| MEDLINE | ID: mdl-25043505
7.
Allosteric TYK2 inhibition: redefining autoimmune disease therapy beyond JAK1-3 inhibitors.
EBioMedicine
; 97: 104840, 2023 Nov.
Article
in English
| MEDLINE | ID: mdl-37863021
8.
The immunology of multiple sclerosis.
Nat Rev Immunol
; 22(12): 734-750, 2022 12.
Article
in English
| MEDLINE | ID: mdl-35508809
9.
Identification of early neurodegenerative pathways in progressive multiple sclerosis.
Nat Neurosci
; 25(7): 944-955, 2022 07.
Article
in English
| MEDLINE | ID: mdl-35726057
10.
Mouse fetal growth restriction through parental and fetal immune gene variation and intercellular communications cascade.
Nat Commun
; 13(1): 4398, 2022 07 29.
Article
in English
| MEDLINE | ID: mdl-35906236
11.
Identifying CNS-colonizing T cells as potential therapeutic targets to prevent progression of multiple sclerosis.
Med
; 2(3): 296-312.e8, 2021 03 12.
Article
in English
| MEDLINE | ID: mdl-33748804
12.
Type II (tositumomab) anti-CD20 monoclonal antibody out performs type I (rituximab-like) reagents in B-cell depletion regardless of complement activation.
Blood
; 112(10): 4170-7, 2008 Nov 15.
Article
in English
| MEDLINE | ID: mdl-18583569
13.
TCR transgenic mice that shed light on immune and environmental regulators in multiple sclerosis.
J Immunol
; 190(7): 3015-7, 2013 Apr 01.
Article
in English
| MEDLINE | ID: mdl-23526826
14.
A novel neurodegenerative spectrum disorder in patients with MLKL deficiency.
Cell Death Dis
; 11(5): 303, 2020 05 01.
Article
in English
| MEDLINE | ID: mdl-32358523
15.
Structural and regulatory diversity shape HLA-C protein expression levels.
Nat Commun
; 8: 15924, 2017 06 26.
Article
in English
| MEDLINE | ID: mdl-28649982
16.
Multiple sclerosis: Molecular mimicry of an antimyelin HLA class I restricted T-cell receptor.
Neurol Neuroimmunol Neuroinflamm
; 3(4): e241, 2016 Aug.
Article
in English
| MEDLINE | ID: mdl-27231714
17.
Resolving TYK2 locus genotype-to-phenotype differences in autoimmunity.
Sci Transl Med
; 8(363): 363ra149, 2016 11 02.
Article
in English
| MEDLINE | ID: mdl-27807284
18.
Invariant NKT cells promote CD8+ cytotoxic T cell responses by inducing CD70 expression on dendritic cells.
J Immunol
; 180(7): 4615-20, 2008 Apr 01.
Article
in English
| MEDLINE | ID: mdl-18354184
Results
1 -
18
de 18
1
Next >
>>